4//SEC Filing
PETERS KEVIN G. 4
Accession 0000899243-19-013764
CIK 0001422142other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:12 PM ET
Size
7.8 KB
Accession
0000899243-19-013764
Insider Transaction Report
Form 4
PETERS KEVIN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-05-14+63,250→ 63,250 totalExercise: $1.04Exp: 2029-05-14→ Common Stock (63,250 underlying) - Award
Stock Option (Right to Buy)
2019-05-14+266,550→ 266,550 totalExercise: $1.04Exp: 2029-05-14→ Common Stock (266,550 underlying)
Footnotes (2)
- [F1]Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.
- [F2]50% of the shares shall vest on June 30, 2020 and the remaining 50% shall vest on June 30, 2021.
Documents
Issuer
Aerpio Pharmaceuticals, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001700663
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:12 PM ET
- Size
- 7.8 KB